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Abstract
Background: Public health benefits from research often rely on the use of data from personal
medical records. When neither patient consent nor anonymisation is possible, the case for
accessing such records for research purposes depends on an assessment of the probabilities of
public benefit and individual harm.
Methods: In the late 1990s, we carried out an observational study which compared the care given
to affluent and deprived women with breast cancer. Patient consent was not required at that time
for review of medical records, but was obtained later in the process prior to participation in the
questionnaire study. We have re-analysed our original results to compare the whole sample with
those who later provided consent.
Results: Two important findings emerged from the re-analysis of our data which if presented
initially would have resulted in insufficient and inaccurate reporting. Firstly, the reduced dataset
contains no information about women presenting with locally advanced or metastatic cancer and
we would have been unable to demonstrate one of our initial key findings: namely a larger number
of such women in the deprived group. Secondly, our re-analysis of the consented women shows
that significantly more women from deprived areas (51 v 31%, p = 0.018) received radiotherapy
compared to women from more affluent areas. Previously published data from the entire sample
demonstrated no difference in radiotherapy treatment between the affluent and deprived groups.
Conclusion: The risk benefit assessment made regarding the use of medical records without
consent should include the benefits of obtaining research evidence based on 100% of the population
and the possibility of inappropriate or insufficient findings if research is confined to consented
populations.
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Background
Many research studies which have led to improvements in
public health benefits have relied on the use of data from
personal medical records [1]. In particular, retrospective
review of medical records has been carried out for many
years in order to answer questions related to the coverage
and equity of health care. When neither patient consent
nor anonymisation is possible, the case for accessing such
records for research purposes depends on an assessment
of the probabilities of public benefit and individual harm.
The past decade has seen a shift in attitude towards using
data derived from medical records without patient con-
sent. Previously, ethics approval for studies involving ret-
rospective use of data was based on a range of
considerations including the relevance and usefulness of
the research question, scientific peer review, suitable data
collection methods and data security. Subject to these
caveats, many studies have been carried out, which
included almost 100% coverage of the target population.
In the current ethical and research governance climate,
primacy tends to be given to considerations of individual
autonomy [2] over considerations of public benefit. It has
become a common view that explicit consent is required
in order to use identifiable personal data for research [3].
However, a growing body of evidence demonstrates that
studies relying solely on patient consent may produce
findings that are unrepresentative [4-7] or misleading [8].
In some instances, ethics committees have permitted an
opt-out arrangement where researchers have been
required to first contact the patient for permission to
review records, and asking them to reply if they object to
their records being reviewed; this is not yet in universal
practice, particularly in cases where, due to the require-
ments of the particular study, records cannot be ano-
nymised. These arguments have not however been
applied to audit which is considered an essential part of
good clinical practice, and for which patient consent is not
required.
Recent analysis of changes in relevant legislation brought
about by the Data Protection Act and the Humans Right
Act, suggest that these laws need not prevent researchers
from using identifiable data without consent, provided
there is a clear public benefit [9]. In this paper, we provide
further evidence of how limiting the use of identifiable
patient data may act against the public interest.
Methods
In the late 1990s, we compared the care provided by the
NHS in Glasgow for all 421 women with breast cancer liv-
ing in affluent and deprived areas [10-12]. Population
coverage by the study was 100% based on ascertainment
of cases from cancer registration and 99% based on hospi-
tal case notes. We then opted to concentrate on patients
who had operable breast cancer (n = 366) and obtained
general practice records relating to 76% (n = 278) of these
women. A postal questionnaire was sent to women whom
we knew to be alive at the time of the general practice
records data (n = 218) collection and whose general prac-
titioners confirmed they were alive and well just prior to
posting the questionnaire. Cases were "lost" for the pur-
pose of this retrospective study at two points: at the gen-
eral practice data collection stage and at the questionnaire
stage. The issue at the point of reviewing general practice
records was that we required practices to facilitate us col-
lecting data from their records; a number of practices did
not engage with the study with respect to this after many
contacts by letter, fax and phone and so we were only able
to review 78% of potential records: we did not request
practices to obtain consent from patients. As we were con-
tacting women several years after their diagnosis of cancer,
we decided to check with general practitioners before
sending out questionnaires as to whether the women were
alive and well.
Ethical approval was obtained for the study, which com-
bined comprehensive record review with a patient ques-
tionnaire five years after diagnosis. Patient consent was
not required at that time for the review of records, but was
given later in the process when women were contacted
and invited to participate in the questionnaire study [12].
In this paper, we summarise the original findings, and add
a parallel set of findings, based only on review of the med-
ical records of the 177 women who took part in the ques-
tionnaire survey, and assuming that, if they had been
asked, these women would also have consented to the
review of their medical records. For the purpose of clarity,
these women are referred to here as the 'consented' sam-
ple.
Results
In our original study, the virtually complete sample of
hospital records allowed us to show equitable provision
of the main treatments for breast cancer – surgery, radio-
therapy and chemotherapy – according to tumour stage.
We also showed that pathological staging information
was not available for 12% of women, mostly from
deprived areas, who presented with more locally
advanced or metastatic tumours [10,11].
In the new analyses reported here, restricted to the hospi-
tal records of the women who gave consent by returning
questionnaires, two findings emerged which are different
from those we reported earlier.
First, although the reduced dataset shows similar findings
to the main study (with wider confidence limits) with
respect to treatments by tumour staging in women pre-
senting with early tumours, it contains no informationBMC Medical Research Methodology 2008, 8:15 http://www.biomedcentral.com/1471-2288/8/15
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about the 12% of women presenting with locally
advanced or metastatic cancer (Table 1).
The second different finding shows that significantly more
women from deprived areas (51 v 31%, p = 0.018)
received radiotherapy compared to women from more
affluent areas (Table 2). Other findings, although with a
smaller sample, were not significantly different from
those originally found and published.
Although the response rate to the questionnaire was 81%,
the women returning a questionnaire comprised only
48% of the original population of women with early
breast cancer. Missing categories comprised women who
had died (n = 20) or left the area (n = 3), and practices
which declined to take part in study (n = 19), did not
respond to requests to see records after numerous contacts
(n = 46), or did not confirm that the patient was alive and
well at time of survey (n = 60).
Discussion
Main findings of this study
In re-analysing the data from our original study, we have
demonstrated different results based on the virtually com-
plete original patient sample and the reduced consented
sample. These differences illustrate some of the conse-
quences and challenges of confining research using per-
sonal medical records to patients who have given explicit
consent.
The original analyses, based on records review without
patient consent, provided largely reassuring information
for the NHS, concerning the equity of provision of major
treatments for women with breast cancer, while avoiding
the uncertain, incomplete and potentially spurious nature
of results based on partial data. The information regarding
clinical staging which we obtained from medical records,
and which had been missed in a previous study based on
pathological records [13], is an important research find-
ing and has contributed to the debate regarding the rea-
sons for the poorer survival of women form socio-
economically deprived areas with breast cancer.
Table 1: Pathological prognostic factors and clinical stage at presentation for women with breast cancer living in affluent and deprived 
areas (whole sample and questionnaire respondents)
AFFLUENT n (%) DEPRIVED n (%) Chi squared test result
PATHOLOGICAL PROGNOSTIC FACTORS
SIZE* WHOLE SAMPLE
n = 136
CONSENTED SAMPLE
n = 72
WHOLE SAMPLE
n = 194
CONSENTED SAMPLE
n = 91
WHOLE 
SAMPLE
CONSENTED 
SAMPLE
0 – 19 mm 70 (51.5%) 42 (58.3%) 106 (54.6%) 54 (59.3%) X2 = 0.53 X2 = 0.04
20 – 49 mm 62 (45.6%) 29 (40.3%) 81 (41.8%) 36 (39.6%) DF = 2 DF = 2
>50 mm 4 (2.9%) 1 (1.4%) 7 (3.6%) 1 (1.1%) p = 0.76 p = 0.98
GRADE* n = 110 n = 59 n = 156 n = 72
1 17 (15.5%) 9 (15.3%) 30 (19.2%) 18 (25.0%) X2 = 0.66 X2 = 1.83
2 67 (60.9%) 39 (66.1%) 92 (59.0%) 42 (58.3%) DF = 2 DF = 2
3 26 (23.6%) 11 (18.6%) 34 (21.8%) 12 (16.7%) p = 0.72 p = 0.34
NODAL 
STATUS*
n = 128 n = 72 n = 196 n = 93
Positive 48 (37.5%) 24 (33.3%) 72 (36.7%) 28 (30.1%) X2 = 0.01 X2 = 0.196
Negative 80 (62.5%) 48 (66.6%) 124 (63.3%) 65 (69.9%) DF = 1
p = 0.88
DF = 2
p = 0.736
CLINICAL STAGE AT PRESENTATION
n = 156 n = 260
Early 146 (93.6%) 100% 220 (84.6%) 100% X2 = 7.42 N/A
Locally
advanced or
metastatic
10 (6.4%) 40 (15.4%) DF = 1
p = 0.006
* Size, grade and nodal status only potentially available for the 366 women (146 affluent and 220 deprived) who had operable breast cancer.
*Total n for whole sample < 366 due to missing data
**Total n for consented sample < 177 due to missing dataBMC Medical Research Methodology 2008, 8:15 http://www.biomedcentral.com/1471-2288/8/15
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The purpose of this part of the original study was to ensure
comparability with previous work by Carnon et al [13].
They studied the relationship between socio-economic
deprivation and pathological prognostic factors in
women with breast cancer, in an attempt to explain the
known poorer survival in socio-economically deprived
areas. They reported that this survival difference was not
related to the stage of disease at the time of presentation.
We confirmed their findings [10] and also produced the
new information that more women from deprived areas
compared to affluent areas presented with locally
advanced or metastatic tumours. This is a small, but
important group of patients, whose exclusion from case
series can produce misleading results. The earlier study
[13] had been a study of pathological records and so had
not included those patients who did not proceed to sur-
gery and therefore for whom prognostic pathological fac-
tors were not available. Although many of the woman
with advanced or metastatic cancer would have been
deceased by the time of our data collection and so we
would likely have been able to obtain their data without
consent, we would argue that having the benefit of the
whole sample enabled us to produce these comparisons
with some confidence.
With respect to our second finding reported here, it is
likely, had we published the spurious finding, based on
smaller numbers, regarding access to radiotherapy that it
0 could have prompted unnecessary concern, and further
research relating to how well women were informed
about treatment options, and also about potential inap-
propriate exposure to radiotherapy.
Limitations of this study
This study presents a hypothetical worst-case scenario
based on a number of assumptions. Our initial assump-
tion is that our study is less likely to receive ethical
approval in the current climate. However, some ethics
committees may be content to provide ethical approval
for a retrospective study of this nature carried out by a suit-
ably qualified researcher within an appropriate context. In
addition, the missing data from Table 1 may have been
available from death records, to which such stringent con-
ditions may not be applied. We have also assumed that
the women who completed questionnaires are likely to
have consented to review of their medical records. This
assumption is likely to have under-estimated the level of
consent as women who did not complete the question-
naire may still have been willing for their records to be
reviewed.
A further limitation is that before we were able to ask
patients to take part in the study by completing the ques-
tionnaire, there was a degree of 'gate-keeping' by general
practitioners who could either not engage with the study
or decided that their patient wasn't suitable to be
included. We were unable to determine which of these
explanations was most pertinent in this study. Gate keep-
ing by clinicians is a feature of studies from health service
lists, and may have both positive and negative aspects
from a research point of view. On the one hand, clinicians
often screen potential lists of participants to exclude
approaches in cases of severe illness or other circum-
stances where an approach would be inappropriate; on
the other hand, clinicians may have no interest in facilitat-
ing research and relegate this task below competing
demands on their time. In either situation, the net effect
in a study such as ours is to increase loss to follow-up. The
role that clinicians may have in gate-keeping in this way is
an important and under-researched area.
Table 2: Surgical treatment, radiotherapy and adjuvant therapy for women living in affluent and deprived areas (whole sample and 
questionnaire respondents)
AFFLUENT n (%) DEPRIVED n (%) Chi squared test result
WHOLE 
SAMPLE
CONSENTED 
SAMPLE
WHOLE 
SAMPLE
CONSENTED 
SAMPLE
WHOLE SAMPLE CONSENTED SAMPLE
BREAST SURGERY n = 142* n = 75** n = 215* n = 97**
Mastectomy 64 (45.1%) 37 (49.3%) 104 (48.4%) 43 (44.3%) X2 = 0.37 DF = 3 X2 = 0.43 DF = 1
Conservation 78 (54.9%) 38 (50.7%) 111 (51.6%) 54 (55.7%) p = 0.54 p = 0.54
AXILLA SURGERY n = 129* n = 70* n = 196 * n = 94**
Clearance 123 (95.3%) 68 (97.1%) 146 (74.5%) 69 (73.4%) X2 = 23.73 DF = 1 X2 = 16.4 DF = 1
Sampling 6 (4.7%) 2 (2.9%) 50 (25.5%) 25 (36.6%) p = 0.0000 p = 0.000
RADIOTHERAPY n = 146
54 (37.0%)
n = 72**
22 (30.6%)
n = 220
90 (40.9%)
n = 98**
50 (51.0%)
X2 = 0.56 DF = 1 p = 0.45 X2 = 5.82 DF = 1 p = 0.018
CHEMOTHERAPY n = 146
29 (19.9%)
n = 75**
13 (16.9%)
n = 220
30 (13.6%)
n = 100**
15 (15%)
X2 = 2.51 DF = 1 p = 0.11 X2 = 0.116 DF = 1 p = 0.84
ENDOCRINE 
THERAPY
n = 146
128 (87.7%)
n = 77
71 (92.2%)
n = 220
196 (89.1%)
n = 100
92 (92.0%)
X2 = 0.17 DF = 1 p = 0.67 X2 = 0.003 DF = 1 p = 1.0
*Total n for whole sample < 366 due to missing data
**Total n for consented sample < 177 due to missing dataBMC Medical Research Methodology 2008, 8:15 http://www.biomedcentral.com/1471-2288/8/15
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Comparison with other studies
This study adds to a growing body of evidence regarding
the implications of confining research to data for which
expressed and specific consent has been given. Others
have shown that consented populations are likely to be
unrepresentative by age or gender [5-7] or may have dif-
ferent clinical outcomes [4,8]. We have added to this by
demonstrating the potential for erroneous conclusions.
In retrospective studies, the proportion of patients who
give informed consent for research access to their records
is affected mainly, not by their individual responses, but
by the numbers whom it is possible to contact. Obtaining
research evidence based on 100% of the population may
therefore be impossible without the use of identifiable
data from medical records. Surveys have shown that most
of the public considers the use of identifiable data by can-
cer registries acceptable [14]. However others have shown
that there is some public concern about the use of data
without consent and demonstrated the need for further
research in this area [15].
Implications of this study
Analyses confined to the hospital records of women who
consented to the postal questionnaire survey, showed a
spurious finding concerning the provision of radiother-
apy for women from deprived areas, and uncertainty con-
cerning the general provision of care, due to small sample
size. It can therefore be argued that requiring informed
consent for research based on patient records may act
against the public interest in obtaining information con-
cerning the success or failure of health policies to provide
equitable care, according to need. Furthermore our main
finding that the NHS provides equitable treatment for
women with breast cancer would have been much less
authoritative had it been based on smaller numbers.
If this work were considered to be audit rather than
research the issues raised here would have been irrelevant.
We viewed it to be research, as did several journals [10-12]
because we were asking a new question of data collected
for clinical purposes. There may be other examples where
the boundary between audit and research is blurred suffi-
ciently for research to be carried out in the name of audit,
so avoiding this difficulty. This is confusing at best and
unethical at worst.
Conclusion
It is debatable whether such our original study would
obtain ethical approval in the current climate, but if the
NHS is to provide and monitor care for 100% of the pop-
ulation, it needs information from studies of this type.
Although anonymisation of patient records should be car-
ried out whenever possible, many research studies require
re-identification of patients in a way that anonymisation
would make impossible. We propose that research studies
based on medical records, for the purpose of reviewing the
coverage and equity of health care should, with appropri-
ate safeguards, be recognised as a class of study for which
individual patient consent is not required. With appropri-
ate publicity, explanation, discussion and debate, we
believe it should be possible to obtain public support for
this approach.
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